Circulating cytokines and gastric cancer risk
- 20 September 2013
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 24 (12) , 2245-2250
Abstract
Chronic inflammation has been hypothesized to play a significant role in the aetiology of cancer, including gastric cancer. In the present study, we sought to examine pre-diagnostic systemic cytokine levels in plasma, which can be seen as markers of aggregate inflammation, and risk of distal gastric cancer in a case–control study nested within the prospective Shanghai Men’s Health Study.Keywords
This publication has 23 references indexed in Scilit:
- Helicobacter pylori Multiplex SerologyHelicobacter, 2009
- How the study of Helicobacter infection can contribute to the understanding of carcinoma developmentClinical Microbiology and Infection, 2009
- Nonsteroidal Antiinflammatory Drugs and Risk of Gastric Adenocarcinoma: The Multiethnic Cohort StudyAmerican Journal of Epidemiology, 2009
- Inflammation, Microenvironment, and the Immune System in Cancer ProgressionCurrent Pharmaceutical Design, 2009
- Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysisBritish Journal of Cancer, 2009
- Prevalence of Obesity and Correlations With Lifestyle and Dietary Factors in Chinese MenObesity, 2008
- Cytokine polymorphisms and gastric cancer risk: An evolving viewCancer Biology & Therapy, 2008
- Intra-individual Variation of Plasma Adipokine Levels and Utility of Single Measurement of These Biomarkers in Population-Based StudiesCancer Epidemiology, Biomarkers & Prevention, 2007
- Dietary patterns and their correlates among middle-aged and elderly Chinese men: a report from the Shanghai Men's Health StudyBritish Journal of Nutrition, 2007
- Serum levels of interleukin 1β, interleukin 8 and tumour necrosis factor α as markers of gastric cancerBiomarkers, 2006